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ery of H1-ATPase activity in IMCD of obstructed kidneysH1-ATPase activity on unilateral ureteral obstruction: Interac-
induced by losartan may be related to a decrease of inducibletion of endogenous nitric oxide and angiotensin II.
NOS activity.Background. A number of cytokines, vasoactive compounds,
chemoattractant molecules, and growth factors are up-regu-
lated in obstruction. Following the onset of ureteral obstruc-
tion, angiotensin II production is rapidly stimulated. Cytokine- Chronic unilateral ureteral obstruction (UUO) is ainduced expression of inducible nitric oxide synthase (iNOS)
well-established model of experimental renal injury [1].has been reported in primary cultures of inner medullary col-
UUO results in changes in renal hemodynamics [2], acid-lecting duct (IMCD) cells. We found that the defective urinary
acidification in unilateral ureteral obstruction (UUO) includes ification duct defect [3], infiltration of the kidney by
an intensive decrease in bafilomycin-sensitive H1-ATPase ac- macrophages [4], and subsequently fibrosis of the tubu-
tivity in microdissected IMCD segments. lointerstitium [5].Methods. To investigate the interaction between endogenous
The invasion of the renal interstitium by macrophagesnitric oxide and angiotensin II on H1-ATPase activity, we used
and T lymphocytes in rats coincides with a decline inmicrodissected IMCD segments of unilaterally obstructed, con-
tralateral, and control kidneys to measure the bafilomycin- renal hemodynamic parameters [6]. Vasoactive com-
sensitive ATPase activity and nitric oxide synthase (NOS) ac- pounds such as angiotensin II, cytokines, and growth
tivity. The generated NO was also evaluated. factors are up-regulated in obstruction. Angiotensin IIResults. Preincubation of obstructed IMCD segments in the
production is rapidly stimulated following the onset ofpresence of a competitive inhibitor of NOS, NG-nitro-l-arginine
ureteral obstruction [7]. Most of the biological effects ofmethyl ester (L-NAME) 1 mmol/L, and in the presence of a spe-
cific inhibitor of calcium/calmodulin-independent NOS (iNOS), angiotensin are transduced by angiotensin II type 1
aminoguanidine 1 mmol/L, each for 60 minutes, significantly in- (AT1) receptor. Expression of AT1 receptor mRNA in
creased bafilomycin-sensitive H1-ATPase. A greater increase the distal tubule includes the cortical and medullary col-on iNOS activity (fmol [3H] citrulline/min/mg protein) and a
lecting duct segments [8].lesser increase in calcium/calmodulin-dependent NOS activity
Angiotensin II, in turn, up-regulates the expression of(cNOS) were observed in the obstructed renal medulla. This
inhibitory effect of obstruction was abolished when IMCDs other factors, including tumor necrosis factor-a (TNF-a),
were incubated with 1025 to 1028 mol/L losartan. Decreasing osteopontin, and nuclear factor-kB [9].
doses of the angiotensin II type 1 (AT1) receptor inhibitor caused In obstruction, up-regulation of TNF-a expression, aan increase in bafilomycin-sensitive H1-ATPase, with a maxi-
proinflammatory peptide produced by monocytes/mac-mum increase at 1028 mol/L losartan. A decrease on iNOS activ-
rophages and resident cells, has been reported in tubularity was demonstrated in the obstructed renal medulla incubated
with losartan in concentrations of 1025 to 1028 mol/L, the same renal cells [10]. TNF-a binding to its receptor activates
losartan concentrations that showed recovery of vacuolar signals of transduction pathways that result in the expres-
H1-ATPase activity. Similarly, a decrease on the generation sion of a variety of transcription factors, other cytokines,of NO after incubation with losartan 1025 to 1028 mol/L was
growth factors, cell adhesion molecules, and mediatorsshown.
of inflammatory processes [11].Conclusion. From these results, we suggest that endogenous
NO increased by iNOS is involved in the inhibition of Exposure to TNF-a induces the expression of an in-
H1-ATPase activity in obstructed IMCD segments. The recov- ducible isoform of nitric oxide synthase (NOS) in the
inner medullary collecting duct cells (IMCDs) [12].
The constitutive neuroneal isozyme of NOS has beenKey words: inducible nitric oxide synthase, losartan, hemodynamics,
fibrosis, renal interstitium, tubulointerstitium, inflammation. localized in the macula densa cells and IMCDs [13].
The expression of inducible NOS (iNOS) mRNA inReceived for publication November 5, 1999
IMCDs microdissected from the normal rat has beenand in revised form March 29, 2000
Accepted for publication April 28, 2000 recently demonstrated by reverse transcription-polymer-
ase chain reaction [14].Ó 2000 by the International Society of Nephrology
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IMCD segments play an important role in renal so- and the left kidneys of the control group were removed.
The kidneys were cut along the corticopapillary axis.dium, water, and acid excretion, and thay are often the
site of injury in inflammatory diseases of the kidney. Slices of 1 mm in thickness were placed into the dissec-
tion solution at 48C without collagenase, and were imme-Studies on H1 secretion in nephron segments in the
post-obstructed kidney have established that the collect- diately microdissected by hand with the aid of fine stain-
less steel needles under a stereomicroscope (310 toing duct is the site of the acidification duct defect [15].
We have previously demonstrated an intense inhibi- 340). IMCD segments measuring between 1 and 1.5 mm
were dissected from the proximal end at the corticomed-tion of bafilomycin-sensitive H1-ATPase in IMCD seg-
ments of unilateral obstructed kidneys [16]. ullary boundary, including the outer third of the inner
medulla. Between 16 and 20 initial IMCD segments wereSeveral important actions of NO in the kidney have
been demonstrated, including regulation of glomerular dissected from each animal. The length of each segment
was measured under the stereomicroscope using an eye-hemodynamics and sodium and water excretion [17], as
well as participation in both immune-mediated [18] and piece micrometer.
hypoxia-reoxygenation–induced renal injury [19].
Assay for H1-ATPase activityEvidence that nitric oxide inhibits proton pump activ-
ity and may thus play a role in the regulation of proton The ATPase activity was measured as described [23]
with minor modifications. Briefly, the microdissected tu-and bicarbonate transport has been shown in cortical
collecting duct (CCD) segments of control rats [20]. bule segments were rinsed in a cold dissection solution,
suspended in the same solution, and transferred to 0.5Preliminary studies by Weiner et al have provided
evidence for an effect of angiotensin II on acid-base mL Eppendorf tubes (1 tubule segment/4 mL). The sam-
ples were frozen until use. After thawing, each sampletransport in the CCD segments of the rabbit [21]. In
support of this suggestion, involvement of angiotensin was incubated in 378C for 15 minutes in the presence of
1 mmol/L adenosine 59-triphosphate (ATP).II in the modulation of an intercalated cell function at
CCD segments has been reported by Tojo, Tisher, and The reaction was stopped by immersing the Eppendorf
tube into a boiling water bath for three minutes. TheMadsen [22].
The present protocol was performed to study whether samples were microcentrifuged, and the free inorganic
phosphate generated during the reaction was measuredendogenous NO is involved in the proton ATPase inhibi-
tion of IMCDs microdissected from unilateral ureteral in the supernatant using the malachite-green colorimet-
ric method, as follows. The supernatant was diluted withobstructed rats, and to demonstrate the interaction be-
tween angiotensin II and NOS on the enzyme activity dissection solution up to 200 mL and mixed with 1 mL
of the malachite-green reagent (0.02%) malachite greenin unilateral obstruction.
oxalate, 0.03% Na2MO4 · 2 H2O, 0.05% Triton X-100,
0.7 mol/L (HCl). An addition of 0.1 mL of 33% sodium
METHODS
citrate solution to every 1 mL of this mixture was made;
Animal model of unilateral urinary obstruction this step stabilizes the color reaction and makes it insensi-
tive to nascent phosphate. After incubating for 30 min-Urinary tract obstruction of the left kidney of female
Wistar Kyoto rats (180 to 200 g) was performed as fol- utes at room temperature, the optical density was read at
600 nm. The standard curve was performed by incubatinglows. Animals were first anesthetized with ether.
Using an aseptic technique, a midline abdominal inci- 200 mL of the known phosphate concentration in solution
with 1 mL of malachite-green reagent. The inorganicsion was performed; the left ureter was completely li-
gated with silk at the union between the pelvis and proxi- phosphate concentration present in the samples was de-
termined from a linear plot of the standards.mal ureter. The abdominal incision was closed with
sutures, the rats were allowed to awaken, and were given The ATPase activity was expressed as the picomole of
inorganic phosphate per minute per millimeter of tubulefree access to water and food. A sham group underwent
a fictitious surgery. A nephrectomy of the left kidney length.
was performed 24 hours after the operation. Rats were
Bafilomycin-sensitive H1-ATPase activityconsidered to have a successful ureteral obstruction
when ureteral dilation was .2 mm at 24 hours. The H1-ATPase activity was measured as the bafilo-
mycin-sensitive ATPase activity. The microdissected tu-
Microdissection of tubule segments bule segments were preincubated for 40 minutes at 378C
with the specific inhibitors ouabain (4 mmol/L), omepra-The kidneys were perfused from the abdominal aorta
with 10 mL of cold dissection solution containing in zole (100 mmol/L), and bafilomycin (10 nmol/L) before
incubating with ATP (discussed previously in this article).(mmol/L) 100 NaCl, 3.7 ClMg, 2 CaCl2, 66.7 NH4Cl, 50
imidazol, and 5.5 glucose to rinse away all of the blood. The bafilomycin-sensitive H1-ATPase activity was de-
fined as the difference between the activity in the pres-The left and right kidneys of the experimental group
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ence of the three inhibitors and in the presence of oua- under a stereomicroscope. After weighing, the medulla
bain-omeprazole without bafilomycin. Bafilomycin is a was immediately frozen on dry ice. Later, the whole tissue
specific inhibitor for the vacuolar H1-ATPase [24]. was homogenized using a glass homogenator (Lightnin
In our assay, we used 10 nmol/L bafilomycin to inhibit Model Mixer-Volts 100; Mixing Equipment Co. Inc.,
the ATPase activity in IMCDs. This bafilomycin concen- Rochester, New York, USA) in a solution (10 mg tissue/
tration was chosen from the lineal regression correlation 100 mL solution) containing N-hydroxyethyl-piperazine-
of increasing bafilomycin doses that were related to the N9-2-ethanesulfonic acid (HEPES)-Tris 10 mmol/L, Saca-
maximal inhibition of H1-ATPase activity tested in con- rose 0.32 mol/L, dithiothreitol (DTT) 1 mmol/L, soybean
trol tubules. For each animal, the H1-ATPase activity tripsin inhibitor 1 mg/100 mL, and Trasylol 2.5 mg/mL to
was determined in triplicate samples for different experi- pH 7.40. The same homogenate of each kidney was used
mental conditions: the presence of Na1,K1-ATPase and for both the measurement of nitrite release and the NOS
H1,K1-ATPase without and with inhibitor of H1-ATP enzyme assay.
ase. The mean value was considered as a single point. The All chemicals were purchased from Sigma (St. Louis,
final result represents the means 6 SEM of 10 animals. MO, USA) unless otherwise noted.
In each experiment, blanks were also run in triplicate to Determination of nitrite release in homogenates from
correct the spontaneous hydrolysis of ATP with time.
renal medulla. We measured the release of nitrite from
kidney using a previously described method [28].Protocol I
Homogenates from each renal medulla from OKs,In all the experiments, intact microdissected tubules
ClKs, and CKs were incubated with 10 mmol/L l-argi-from the obstructed kidney (OK), contralateral kidney
nine in a buffer (pH 7.40) containing 25 mmol/L HEPES,(ClK), and control kidney (CK) were preincubated in
140 mmol/L NaCl, 5.4 mmol/L KCl, 1.8 mmol/L CaCl2,assay buffer containing the various compounds to be
1 mmol/L MgCl2 and 5 mmol/L glucose at 378C for 24 hours.tested. After preincubation, the tubules were transferred
After centrifugation at 6400 r.p.m. during 20 minutes,to fresh assay buffer and subjected to freezing and thaw-
the supernatants were used for the assay of NO2 produc-ing before determination of H1-ATPase activity, as de-
tion, and the amount of NO22 was corrected by means ofscribed previously in this article.
the protein amount, measured according to the BradfordEffect of L-NAME on H1-ATPase activity. To exam-
method using bovine serum albumin as a standard (Bio-ine whether inhibition of H1-ATPase activity is caused
Rad, Richmond, CA, USA) [29].by induction of endogenous NO in intercalated cells of
IMCD, incubation of the microdissected segments of Nitrite was measured by a spectrophotometer at a
OKs, ClKs, and CKs was performed for 60 minutes in the 540 nm wavelength using the Griess reaction [30]. The
presence of 1 mmol/L NG-nitro-l-arginine methyl ester NO present was expressed as picomoles of nitrite gener-
(L-NAME), a competitive inhibitor of NOS [25], before ated per milligram of proteins per minute.
measuring the bafilomycin-sensitive H1-ATPase activity. Aliquots of renal medulla homogenates from CKs
Effect of aminoguanidine on H1-ATPase activity. In (N 5 8) were incubated with 10 mmol/L l-arginine and
another series of experiments, we examined the effect of with the NOS inhibitor, 20 mmol/L L-NAME, for 24
aminoguanidine, a relatively selective inhibitor of iNOS hours to ensure that NO was produced in the homoge-
[26], on bafilomycin-sensitive H1-ATPase activity. Mi- nates of renal medulla.
crodissected IMCD tubule segments of OKs, ClKs, and Determination of NOS activity. Nitric oxide synthase
CKs were incubated for 60 minutes in the presence of activity was quantitated by measuring the conversion of
aminoguanidine 1 mmol/L, before the measurement of L-[3H] arginine to L-[3H] citrulline, using the presence
bafilomycin-sensitive H1-ATPase activity. of saturating concentrations of the enzyme’s cofactors
Effect of AT1 receptor inhibition on H1-ATPase ac- as previously described [31] with minor modifications.
tivity. We evaluated the involvement of angiotensin II Homogenates from renal medulla were centrifugated
through its AT1 receptor on the inhibition of H1-ATPase at 3000 r.p.m. at 48C for 10 minutes. A 40 mL aliquotactivity, using a specific inhibitor of the AT1 receptor, of the each supernantant fraction was incubated withlosartan [27].
3 mmol/L CaCl2, 1 mmol/L NADPH, 25 mmol/L FAD,The individual microdissected IMCD segments of
1.25 mg/mL calmodulin, 10 mmol/L tetrahydrobiopterin,OKs, ClKs, and CKs were incubated in an assay buffer
and [3H] arginine (approximately 300,000 cpm, 6.8containing losartan at concentrations ranging from 1025
Ci/mL) in 20 mmol/L HEPES buffer (reaction buffer),to 1028 mol/L for 60 minutes at 378C before the determi-
pH 7.40, at 378C for 30 minutes. Calcium/calmodulin-nation of H1-ATPase activity.
independent NOS activity was measured by using the
Protocol II same buffer and cofactors, without calcium and calmodu-
lin, after the addition of 0.5 mmol/L ethylenediaminetet-Bilateral nephrectomy from obstructed and control
raacetic acid (EDTA). Parallel reactions were analyzedether anesthetized rats was performed. Slices from the
kidney were done, and the renal medulla was removed in the presence of L-NAME 20 mmol/L, an inhibitor of
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the inducible and constitutive isoforms of NO synthase, In IMCD of OKs, bafilomycin-sensitive H1-ATPase
in the renal medulla of CKs. The reaction was stopped activity was significantly decreased in comparison to the
by the addition of the L-NAME–20 mmol/L HEPES enzyme activity in microdissected IMCD of ClKs (P ,
buffer (100 mL) at 48C. The total volume (210 mL) was 0.01) and CKs (P , 0.01; Fig. 1).
applied to a Dowex 50 W-X8, 100 to 200 mesh column To determine whether endogenous NO was involved
(volume 0.6 mL) that had been pre-equilibrated with 20 in the inhibition of bafilomycin-sensitive H1-ATPase
mmol/L HEPES (7.40) and saturated with 20 mmol/L activity present in unilateral obstruction, the effect of
of cold citrulline. [3H] citrulline was eluted with 200 mL L-NAME, a specific inhibitor of cNOS and iNOS, was
of deionized water, and radioactivity was quantitated by studied. Incubation of IMCD of OK with 1 mmol/L
scintillation counting (Wallac, LK Beta Rack, Finland). L-NAME for 60 minutes showed a significant increase
Blanks included 50 mL of homogenate buffer plus 60 mL on bafilomycin-sensitive H1-ATPase activity (18.09 6
of reaction buffer without or with calcium/calmodulin for
1.21 vs. 40.53 6 1.96 pmol inorganic phosphate/min/mm;measuring iNOS and cNOS, respectively. The results are
P , 0.01). After 60 minutes of incubation with L-NAMEexpressed as fmol [3H] citrulline/mg protein/min incubation.
1 mmol/L, no difference was observed in the H1-ATPaseProtein concentrations were measured according to
activity of ClKs (69.73 6 1.80 vs. 77.77 6 2.20 pmolBradford by using a Bio-Rad reagent [29]. Bovine serum
inorganic phosphate/min/mm) and CKs (61.18 6 1.67 vs.albumin was used as standard (1 mg/mL).
63.20 6 2.45 pmol inorganic phosphate/min/mm; Fig. 1).
Experimental protocols We also examined the effect of an inhibitor of induc-
ible NOS, aminoguanidine, on bafilomycin-sensitiveEffect of losartan on nitrite release in renal medulla
H1-ATPase activity. Incubation of IMCD segments withhomogenates. We measured the nitrite release from re-
nal medulla homogenates in OKs, ClKs, and CKs after aminoguanidine 1 mmol/L for 60 minutes was associated
the tissues were incubated in the presence of losartan at with a significant increase of H1-ATPase activity on OKs
concentrations ranging from 1025 to 1028 mol/L, for five (from 18.09 6 1.21 to 45.33 6 2.42 pmol inorganic phos-
hours at 378C. phate/min/mm; P , 0.01).
Simultaneously, an aliquot from renal papilla homoge- After 60 minutes of incubation with aminoguanidine
nates from CKs was incubated with 20 mmol/L L-NAME 1 mmol/L, no significant increase was observed on the
for five hours to ensure that NO was produced in the enzyme activity in ClKs, 69.73 6 1.80 versus 77.90 6
kidney homogenates. 4.07, and CK, 61.18 6 1.67 versus 62.54 6 1.81 pmol
Effect of losartan on NOS activity in renal medulla ho- inorganic phosphate/min/mm (Fig. 1).
mogenates. To evaluate the interaction between angioten-
sin II and endogenous nitric oxide, preincubation of renal Effect of angiotensin II on H1-ATPase
medulla homogenates in the presence of an inhibitor of activity in obstruction
the AT1 receptor, losartan, on concentrations ranging
To determine the participation of angiotensin II onfrom 1025 to 1028 mol/L for five hours was performed.
the inhibition of bafilomycin-sensitive H1-ATPase activ-After incubation with losartan, the calcium/calmodulin-
ity in obstruction, we examined the effect of an angioten-dependent NOS activity (cNOS) and calcium/calmodulin-
sin II type 1 (AT1) receptor inhibitor, losartan, at differ-independent NOS activity (iNOS) were measured in the
ent concentrations on individual IMCD segments.medulla homogenates from OKs, ClKs, and CKs.
The effect of incubation of individual IMCD segments
Statistical analysis with losartan at concentrations ranging from 1025 to 1028
The results were assessed by one-way analysis of vari- mol/L for 60 minutes at 378C on bafilomycin-sensitive
ance for comparisons between groups. Significance of H1-ATPase activity is illustrated in Figure 2.
differences was estimated by Bonferroni’s test. With decreasing concentrations of losartan, there was
Student’s test was used to compare the means when a gradual increase in the recovery of H1-ATPase activity.
the experimental design consisted of two samples. Statis- The strongest recovery of the enzyme activity was dem-
tical significance was assessed by Student’s impaired onstrated at 1028 mol/L of losartan.
t-test. A P , 0.05 was considered to be significant. Re- In ClKs, no statistical differences were observed after
sults are given as means 6 SEM. the incubation with losartan at concentrations from 1025
to 1028 mol/L: 69.73 6 1.80 versus 72.66 6 4.63
RESULTS (1025 mol/L), 72.63 6 3.29 (1026 mol/L), 73.75 6 4.42
Effect of endogenous NO on H1-ATPase (1027 mol/L), and 75.66 6 1.90 (1028 mol/L). There was
activity in obstruction no effect of losartan concentrations from 1025 to 1028
mol/L on control IMCD proton ATPase activity: 61.18 6The compromise of H1-ATPase activity on obstruc-
1.67 vs. 54.40 6 1.35 (1025 mol/L), 56.16 6 1 (1026 mol/L),tion was evaluated by means of the bafilomycin-sensitive
ATPase activity. 53 6 1.20 (1027 mol/L), and 56 6 2 (1028 mol/L).
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Fig. 1. Bafilomycin-sensitive ATPase activ-
ity in rat inner medullary collecting duct
(IMCD) segments after 24 hours of unilateral
ureteral obstruction. Symbols are: (h) control
(N 5 10); ( ) contralateral (N 5 10); (j)
obstructed kidney (OK; N 5 10). Effect of
L-NAME, a competetive inhibitor of nitric
oxide synthase (NOS), on bafilomycin-sensi-
tive ATPase activity in rat IMCD. Tubules
were incubated with L-NAME 1 mmol/L for
60 minutes at 378C. A significant increase on
bafilomycin-sensitive H1-ATPase activity in
IMCD of OK is shown (**P , 0.01). Effect
of 1 mmol/L aminoguanidine (AMG), an in-
hibitor of inducible NOS (iNOS), on bafilo-
mycin-sensitive ATPase activity in rat IMCD.
Tubules were incubated with aminoguanidine
1 mmol/L for 60 minutes at 378C. We found
a significant increase in bafilomycin-sensitive
H1-ATPase activity in IMCD of OK (**P ,
0.01). Values are mean 6 SEM.
Fig. 2. Effect of losartan at concentrations of
1025 to 1028 mol/L on unilateral obstruction-
mediated inhibition of H1-ATPase activity in
rat IMCD. Tubules were incubated with losar-
tan for 60 minutes at 378C. Decreasing doses
of losartan increased H1-ATPase activity.
NOS activity on renal medulla tissue in obstruction 0.02 fmol [3H] citrulline/min/mg protein; P , 0.01) was
demonstrated (Fig. 3).Nitric oxide synthase activity was quantitated by mea-
There was a slight but significant increase in calcium/suring the conversion of L-[3H] arginine to L-[3H] citrul-
calmodulin-dependent NOS activity in the medulla ofline. When homogenates from renal medulla tissue of
the obstructed rat kidneys when compared with medullaOKs were incubated in the presence of saturating con-
of contralateral rat kidneys (0.60 6 0.03 vs. 0.41 6 0.02,centrations of the enzyme cofactors, without calcium/
P , 0.05) and control (0.60 6 0.03 vs. 0.26 6 0.01 fmolcalmodulin, a significant increase in activity of calcium/
[3H] citrulline/min/mg protein; P , 0.05; Fig. 3).calmodulin-independent NOS (iNOS) related to ClKs
The interaction between angiotensin II and NOS activ-(0.89 6 0.04 vs. 0.47 6 0.02 fmol [3H] citrulline/min/mg
protein; P , 0.01) and CKs (0.89 6 0.04 vs. 0.41 6 ity was evaluated in obstruction. Preincubation of renal
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decrease in NOS activity. No differences in the homoge-
nates of the renal medulla of CKs were observed in
calcium/calmodulin-independent and -dependent NOS
activity (Fig. 4).
The addition of 20 mmol/L L-NAME caused a signifi-
cant decrease in the generation of [3H] citrulline in the
renal medulla of CK (0.41 6 0.02 vs. 0.19 6 0.02; P ,
0.05), indicating that [3H] citrulline formation closely
reflected renal NO synthesis.
Determination of nitrite
Consistent with the NOS data, measurement of nitrite
generated from the homogenates of renal medulla from
the 24-hour obstructed kidneys was significantly higher
compared with the same tissue of ClKs (38.80 6 2.27 vs.
25.67 6 0.95, P , 0.01) and CKs (38.80 6 2.27 vs. 28.3 6
0.67 nmol NO2 generated/min/mg protein, P , 0.01; Fig. 5).
Measurement of nitrite generated from the papilla of
OKs incubated in the presence of losartan in doses of
1025 to 1028 mol/L demonstrated a decrease on nitrite
excretion with decreasing doses of losartan in a dose-
dependent manner [38.80 6 2.27 vs. 32.01 6 0.81 nmol
NO2 generated/min/mg protein (1025 mol/L), 18.90 6
1.56 nmol NO2 generated/min/mg protein (1026 mol/L)].
A maximum decrease of nitrite excretion was observed
in homogenates of OKs with a losartan dose of
1028 mol/L (38.80 6 2.27 vs. 9.14 6 0.57 nmol NO2 gener-
ated/min/mg protein).
We observed that the smaller the concentration of
losartan, the higher the decrease in the nitrite generation
in the homogenate of the renal obstructed medulla. AFig. 3. Nitric oxide synthase activity in rat renal papilla homogenates
small decrease of nitrite excretion was observed on ho-after 24 hours of unilateral obstruction from (h) control (CK; N 5 22),
( ) contralateral (ClK; N 5 22), and (j) obstructed (OK; N 5 22) mogenates from renal medulla of ClKs (25.67 6 0.95 vs.
kidneys. (A) Calcium/calmodulin-independent nitric oxide synthase ac- 19 6 1.10 nmol NO2 generated/min/mg protein, P ,tivity (iNOS). **P , 0.01, OK vs. ClK and OK vs. CK. (B ) Calcium/
0.059) after losartan 1025 mol/L administration. No dif-calmodulin-dependent NO activity (cNOS). *P , 0.05, OK vs. ClK and
OK vs. CK. Values are mean 6 SEM. ferences were observed on homogenates from ClKs after
losartan 1026 mol/L (25.67 6 0.95 vs. 22.90 6 1.52) and
1028 mol/L (25.67 6 0.95 vs. 23.88 6 1.60 nmol NO2
generated/min/mg protein). Renal medulla from controlsmedulla tissue of OKs for five hours with concentrations
showed no differences after incubation for five hours in
of 1025 to 1028 mol/L losartan induced a sharp decrease the presence of losartan at concentrations from 1025 to
of calcium/calmodulin-independent NOS activity (Fig. 4). 1028 mol/L [28.30 6 0.67 vs. 26.06 6 0.97 (1025 mol/L),
A lesser decrease of calcium/calmodulin-dependent 24.13 6 1.78 (1026 mol/L), and 21.86 6 1.17 nmol NO2NOS activity was observed in the renal medulla of OKs generated/min/mg protein (1028 mol/L); Fig. 5].
after incubation of 1025 to 1028 mol/L losartan for five
hours (Fig. 4).
DISCUSSIONMeasurement of calcium/calmodulin-independent and
calcium/calmodulin-dependent NOS activity on homog- The results of this study demonstrate that endogenous
nitric oxide is involved in the H1-ATPase inhibition inenates of the renal medulla of ClKs showed a small
c
Fig. 4. Effect of losartan 105 to 108 mol/L on nitric oxide synthase activity in rat renal medulla. Renal medulla homogenates were incubated with
losartan for five hours at 378C. (A) There was an intensive decrease of calcium/calmodulin-independent NOS activity in OKs (**P , 0.01) and a
decrease of calcium/calmodulin-dependent NOS activity in OKs (N 5 7; *P , 0.05) after incubation with losartan. (B ) Calcium/calmodulin-
independent and -dependent NOS activity in ClKs, (N 5 7), after incubation with losartan. (C ) Calcium/calmodulin-independent and -dependent
NOS activity in CKs (N 5 7), after incubation with losartan. Values are mean 6 SEM.
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IMCD segments microdissected from unilateral OKs. The
intensive inhibition of bafilomycin-sensitive H1-ATPase
activity in IMCD segments obstructed for 24 hours was
reversed after incubation of the duct segments in the
presence of a competitive inhibitor of NOS, L-NAME.
A significant increase in bafilomycin-sensitive H1-ATPase
in obstructed IMCD was shown after incubation in the
presence of L-NAME.
There was no effect of L-NAME on the bafilomycin-
sensitive H1-ATPase activity in the isolated IMCD from
the contralateral and CKs.
Because bafilomycin is considered to be a specific in-
hibitor of the vacuolar H1-ATPase at the concentration
used in our experiments, the nitric oxide generated dur-
ing obstruction may be involved in the regulation of the
vacuolar proton ATPase in the intercalated cells.
High levels of the electrogenic vacuolar H1-ATPase
have been found in the intercalated cells of the connect-
ing and collecting tubules, in outer medullary collecting
ducts (OMCD), and in intercalated cells of IMCD. The
presence of A type intercalated cells has been demon-
strated on the initial segments of the IMCD tubules, the
duct segments used in our present study [32].
Immunocytochemical studies have shown that in unilat-
eral obstruction, morphological changes in H1-ATPase
included the appearance of a gap in apical H1-ATPase
staining of the intercalated cells, suggesting an impairment
in the cytoskeletal translocation of the enzyme in the
inner medulla [33]. We have previously shown an intensive
decrease in the bafilomycin-sensitive H1-ATPase activity
in medullary collecting duct segments with lesser degree
of the proton activity in the CCD segments after 24 hours
of unilateral ureteral obstruction [16].
In our present study, a significant recovery of bafilo-
mycin-sensitive H1-ATPase in obstructed IMCD seg-
ments was also induced by aminoguanidine, a selective
inhibitor of the inducible isoform of NO synthase, with
a Ki value that is 32 to 52 times less for iNOS than for
constitutive NOS [34].
A slight increase of the enzyme activity was observed
in obstructed IMCD with aminoguanidine in comparison
to the incubation of the same injured IMCD in the pres-
ence of L-NAME. According to this latest finding, evi-
dence of an intensive increase of calcium/calmodulin-
independent NOS activity (iNOS) in homogenates from
b
Fig. 5. Effect of 105 to 108 mol/L losartan on the generation of endoge-
nous nitric oxide in rat renal medulla. Renal medulla homogenates
were incubated with losartan for five hours at 378C. (A) An intensive
dose-dependent decrease on the nitrite generation in obstructed kidneys
(OKs; N 5 7), after incubation with losartan (**P , 0.01). (B ) Nitrite
generation in contralateral kidneys (CLKs; N 5 7), after incubation
with losartan (*P , 0.05). (C ) Nitrite generation in control kidneys
(CKs N 5 7) after incubation with losartan. Values are mean 6 SEM.
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the renal papilla of OKs was shown in our study, whereas eral obstruction. With regards to regulation of the en-
zyme by NO, vacuolar H1-ATPase from synaptic vesiclesa lower activity of iNOS was observed in the renal papilla
of ClKs and CKs. of rat brain has recently been demonstrated to be inhib-
ited by NO with a mechanism that involves S-nitrosyla-In this experimental model of unilateral ureteral ob-
struction, a number of cytokines, vasoactive substances tion of critical sulfhydryl groups of the enzyme [42].
The possibility that cGMP also regulates the H1-ATPasesuch as angiotensin II, chemoattractant molecules, and
growth factors, are up-regulated. These inflammatory cy- activity via an indirect signaling pathway in the cells has
been suggested previously [20].tokines have proved to activate inducible NOS gene tran-
scription in IMCDs [12]. Recent evidence also suggests Increased expression of angiotensin II mRNA has
been demonstrated in the early phase of unilateral ob-that iNOS may be constitutively expressed in normal rats.
Since basal iNOS gene expression is high in medullary struction. The presence of the angiotensin II type 1 (AT1)
receptor in the distal tubule, including medullary collect-thick ascending limb and IMCD segments that normally
function in a relatively hypoxic environment, the recent ing ducts, has been supported by both biochemical and
molecular biological studies [8]. The AT1 receptor trans-discovery that iNOS is a hypoxia-inducible gene provides
at least one mechanism that may account for the constitu- duces much of the biological effects of angiotensin.
Our study shows that H1-ATPase activity was nottive expression of iNOS in these segments [35]. Results
of an increased iNOS compared with cNOS activity in inhibited when the obstructed IMCD was incubated with
losartan, an antagonist of AT1 receptor. When the con-renal medulla of CKs in our study suggests a higher basal
activity of iNOS. centrations of losartan were decreased from 1025 to 1028
mol/L, there was a corresponding gradual increase inThe two major constitutive NOS isozymes expressed
in IMCD segments—nNOS and eNOS—exhibit a strict H1-ATPase activity, and the maximum recovery of the
enzyme activity was observed at the concentration ofdependency on intracellular calcium/calmodulin.
By using reverse transcription-polymerase chain (RT- 1028 mol/L losartan.
Previously, Tojo, Tisher, and Madsen showed that pre-PCR) reaction in microdissected renal segments, Terada
et al observed nNOS mRNA principally in the inner incubation of control CCD segments with 1028 to 1025
mol/L angiotensin II had a specific dose-dependent in-medullary collecting ducts [13]. The eNOS mRNA and
its protein have been reported in renal cortex and me- hibitory effect on the vacuolar H1-ATPase, with a maxi-
mum inhibition at 1028 mol/L angiotensin II [22].dulla of the rat [36]. Although they are classified as
constitutive enzymes, the expression of nNOS and eNOS Because of the increased angiotensin converting en-
zyme (ACE) activity and despite a very low amount ofis regulated by specific physiological and pathophysio-
logical stimuli, including increases in local vascular resis- renin mRNA, nonsuppressed angiotensin II levels were
found in unilaterally obstructed ClKs in relation to CKstance that enhances shear stress [37] and hypoxia [38].
In unilateral obstruction, renal hemodynamics include by El-Dahr et al [43]. Although our results in renal me-
dulla homogenates from ClKs showed a small decreasea selective increase in renal vascular resistance and a
decrease in the glomerular filtration rate of the ipsilater- in the calcium/calmodulin-independent and -dependent
NOS activity induced by 1025 to 1028 mol/L losartan,ally obstructed kidney.
Even though the calcium/calmodulin-dependent nitric we cannot suggest that there is an interaction between
endogenous nitric oxide and angiotensin II through itsoxide activity (cNOS) in the OK was higher than that
of the ClK and CK, iNOS activity in the OK was signifi- AT1 receptor in the contralateral kidney.
Our results do suggest that, through its AT1 receptor,cantly increased when compared with the cNOS activity
in this impaired kidney. angiotensin II is involved in the vacuolar proton ATPase
inhibition in obstruction.Thus, our results suggest the presence of an early in-
ducible isoform of NOS activation in this tubule segment. No effect of the angiotensin II type 2 (AT2) receptor on
the inhibition of H1-ATPase activity has been previouslyWe also showed that there was an increased genera-
tion of nitrite in the renal medulla of the OK. reported [22].
Because of the recovery of the proton ATPase activityL-NAME, an inhibitor of both l-arginine transport
and NOS activity, blocks NO production in the ob- to near control values after the incubation of obstructed
IMCD in the presence of losartan in doses from 1025 tostructed renal medulla.
Nitric oxide has several important functions in the kid- 1028 mol/L, and the previously mentioned results of an in-
crease on the proton ATPase activity of obstructed IMCDney [39–40]. In obstruction the role of endogenous nitric
oxide, an endothelial-derivated relaxing factor (EDRF), in in the presence of L-NAME and aminoguanidine, we
looked for the relationship between endogenous NO andthe regulation of renal hemodynamics has been previously
investigated by Chevalier, Thornhill and Gomez [41]. angiotensin II on the regulation of the enzyme activity.
A decrease in calcium/calmodulin-independent activ-Our present results show that endogenous NO partici-
pates in the vacuolar proton ATPase inhibition in unilat- ity (iNOS) was demonstrated in the obstructed renal
Valles and Manucha: H1-ATPase activity in obstruction1650
medulla incubated with 1025 to 1028 mol/L losartan, the In renal epithelial cells, the mechanisms that trigger
the increases of (Ca21)i and NO during cell injury involvesame losartan concentrations that showed a recovery of
vacuolar H1-ATPase activity. Similarly, lower values of the activation of G-protein–coupled receptors for sub-
stances such as angiotensin II, thromboxane, and throm-cNOS activity were shown after the incubation of the
obstructed renal medulla in the presence of decreasing bin. Activation of a G protein, Ga13, specifically induces
expression of iNOS in renal epithelial cells, demonstra-concentrations of the AT1 receptor antagonist (1025 to
1028 mol/L losartan). ting that G-protein–dependent signaling systems are ca-
pable of inducing iNOS and, hence, an increase in NOThe comparison between the calcium/calmodulin-in-
dependent NOS activity (iNOS) in renal medulla of OKs levels [47].
The expression of guanosine 5-triphosphate (GTP)-before and after incubation with losartan showed a more
important decrease in iNOS activity than the one related binding protein (G proteins) associated with H1-ATPase
activity in intercalated cells of the rat medulla with ato cNOS activity.
In agreement with these latter results, a dose depen- functional up-regulation of the pump has been reported.
It has been suggested that the H1-ATPase can be directlydent decrease in the nitrite generation was also demon-
strated after incubating the obstructed renal medulla regulated by a G protein or indirectly via an intermediate
with decreasing concentrations of losartan, from 1025 to second messenger, such as adenosine 3-5’-cyclic mono-
1028 mol/L, with the lowest dose (1028 mol/L) inducing phosphate, although the particular G protein involved
the greatest decrease in nitrite. remains to be identified [48].
According to our results, an interaction between the Because of these results, we conclude that endogenous
vasoconstrictor peptide angiotensin II through it AT1 re- NO, while mainly increased by iNOS, is involved in the
ceptor and the endogenous vasodilator nitric oxide at the inhibition of H1-ATPase activity of IMCD segments. The
level of H1-ATPase in the obstructed IMCD segments recovery of H1-ATPase activity in IMCD segments of
was demonstrated. obstructed kidneys induced by losartan could be related
Thus, angiotensin II and endogenous nitric oxide in- to a decrease of the inducible nitric oxide synthase activity.
fluence each other’s functions in unilateral ureteral ob-
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